Private equity swoops on UK companies
Private equity firms have struck 13 deals in Britain so far this year worth a total of almost $31bn – more than double the number for the whole of 2020.

“Buyout firms have struck 13 so-called public-to-private deals in Britain so far this year for a total value of almost $31bn,” says Ben Dummett in The Wall Street Journal. That’s more than double the number for the whole of last year and the best performance over the same period since 2007.
Private-equity funds invest in private companies or buy out publicly listed ones. The bidding war for Wm Morrison Supermarkets has only been the most “high-profile” example of the trend. Healthcare, property and defence businesses are also being snapped up.
Why the boom? Private-equity firms have “mounds of low-cost debt to make acquisitions” thanks to low interest rates. But takeovers usually require the buyer to pay a premium, which is difficult to justify in the pricey US market.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Britain, by contrast, is cheap. Data from broker Peel Hunt shows that on a forward 12-month price/earnings basis Britain is “40% cheaper than the US market and 25% cheaper than the eurozone”, says cmcmarkets.com. “S&P 500 firms typically trade at 23 times earnings, compared with just 14 times in London.”
Britain’s quiet IPO boom
The private-equity bidding war is good for share prices. But it has also caused concern about the long-term health of the London market. If private firms delist some of Britain’s best businesses, then what will remain for ordinary investors?
Not to worry, says Simon Foy in The Daily Telegraph. As quickly as firms are going private, plenty of new ones are coming onto the market. “Since the beginning of the year, 54 companies, with a combined market value of £53bn, have floated on the London Stock Exchange”.
There is a widespread impression that the London bourse is “struggling”. That’s thanks to Deliveroo’s “high-profile flop” – shares in the food-delivery app plunged 26% after listing in March. But as Simon French of Panmure Gordon notes, “if you took an equal stake in each of the companies that have floated this year, your investment would be up by about a third in the year to date”, beating the wider FTSE All-Share’s gain of 7.8%.
Investors are often warned against having a “home bias”, says David Brenchley in The Times. Almost half of British investors told a Quilter survey that “more than 50% of their investments were in the UK…One in 12 people with more than £60,000 invested admitted to having all of their investments in UK stocks”. Investors who failed to diversify globally have paid the price over the past decade as US markets soared while the FTSE stagnated, but that trend will reverse at some point. Remember that “for a long time before the financial crisis, UK stocks beat American ones”. It’s never a good idea to put all your eggs in one basket, but a touch of home bias looks a sound strategy for now.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Barclays begins paying up to £100 compensation to customers after banking outage
Barclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
By Daniel Hilton Published
-
Review: Shangri-La Paris – an ode to the world’s best food
Natasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
By Natasha Langan Published
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge Published
-
Bargain Britain boasts both value and momentum
Interview Ian Lance, manager of the Temple Bar Investment Trust, tells Andrew Van Sickle that the outlook for UK stocks has improved and healthy long-term returns are in prospect
By Andrew Van Sickle Published
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge Published
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field Published
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs Published
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward Published
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves Published
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine Published